1. The supply and demand for medicines inquiry: The Committee will take evidence from-
Dr Ewan Bell, National Clinical Lead, Area Drug and Therapeutics Committee Collaborative, Healthcare Improvement Scotland;
Matt Barclay, Director of Operations, Community Pharmacy Scotland;
Dr Scott Jamieson, Royal College of General Practitioners;
David Coulson, Assistant Director of Pharmacy, NHS Tayside;
and then from—
Eileen McKenna, Associate Director Professional Practice, Royal College of Nursing Scotland;
Jonathan Burton, Chair, Scottish Pharmacy Board, Royal Pharmaceutical Society in Scotland;
Lewis Morrison, Chair of BMA Scotland, British Medical Association.

2. Subordinate legislation: The Committee will consider the following negative instruments—
The Foods for Specific Groups (Infant Formula and Follow-on Formula) (Scotland) Regulations 2020 (SSI 2020/6); The Foods for Specific Groups (Medical Foods for Infants) and Addition of Vitamins, Minerals and Other Substances (Scotland) Amendment Regulations 2020 (SSI 2020/7).

3. The supply and demand for medicines inquiry (in private): The Committee will consider the evidence heard earlier in the meeting.